About
Before founding Medpace, Troendle was a manager at Sandoz (Novartis) from 1987 to 1992, where he was responsible for the clinical development of lipid-altering agents. From 1986 to 1987 he worked as a Medical Review Officer in the Division of Metabolic and Endocrine Drug Products at the U.S. Food and Drug Administration. He received his medical degree from the University of Maryland School of Medicine and a Master of Business Administration from Boston University. Other healthcare leaders with pages on Whoo include Marc Casper of Thermo Fisher Scientific and Mike Mahoney of Boston Scientific.
Whoo compiled this page from public sources: Medpace leadership page, Medpace 2026 proxy statement (SEC filing), Medpace 2025 annual report (Form 10-K). It is not affiliated with or endorsed by August Troendle. Are you August Troendle? Claim this page, or write to [email protected] to correct or remove it. Last updated: 2026-11-18.
Want a page like this? Create yours from your résumé.
Experience
Chief Executive Officer and Chairman of the Board — Medpace
July 1992 – Present | Cincinnati, Ohio
- Founded the company in July 1992
- Responsible for the clinical development of lipid-altering agents
- Worked in the Division of Metabolic and Endocrine Drug Products
Manager — Sandoz (Novartis)
1987 – 1992
Medical Review Officer — U.S. Food and Drug Administration
1986 – 1987